Results 121 to 130 of about 12,924 (266)
Immunological Reviews, Volume 328, Issue 1, Page 221-242, November 2024.Summary Advances in antibody technologies have resulted in the development of potent antibody‐based therapeutics with proven clinical efficacy against infectious diseases. Several monoclonal antibodies (mAbs), mainly against viruses such as SARS‐CoV‐2, HIV‐1, Ebola virus, influenza virus, and hepatitis B virus, are currently undergoing clinical testing
Julia E. Edgar, Stylianos Bournazos
wiley +1 more source
A seroepidemiologic study of Reston ebolavirus in swine in the Philippines [PDF]
BMC Veterinary Research, 2012 Abstract Background Ebola viruses cause viral hemorrhagic fever in humans and non-human primates and are endemic in Africa. Reston ebolavirus (REBOV) has caused several epizootics in cynomolgus monkeys (Macaca fascicularis) but is not associated with any human disease. In late 2008, REBOV infections were identified in
Rachel R. Azul +21 more
openaire +4 more sources
Testing New Hypotheses Regarding Ebolavirus Reservoirs
Viruses, 2016 Despite a relatively long search for the origin of ebolaviruses, their reservoirs remain elusive. Researchers might have to consider testing alternative hypotheses about how these viruses persist and emerge to advance ebolavirus research.
Siv Aina Jensen Leendertz
doaj +1 more source
Human Vaccines & Immunotherapeutics, 2021 Clinical development of Ebola virus vaccines (EVV) was accelerated by the West African Ebola virus epidemic which remains the deadliest in history. To compare and rank the EVV according to their immunogenicity and safety.
Alhassane Diallo +7 more
doaj +1 more source
Ebolavirus and evidence-based speculations.
The new microbiologica, 2016 .
Focosi, Daniele +2 more
openaire +4 more sources
A Bayesian analysis of birth pulse effects on the probability of detecting Ebola virus in fruit bats
Peer Community JournalSince 1976 various species of Ebolavirus have caused a series of zoonotic outbreaks and public health crises in Africa. Bats have long been hypothesised to function as important hosts for ebolavirus maintenance, however the transmission ecology for these
Pleydell, David R.J. +6 more
doaj +1 more source
Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries [PDF]
, 2014 There is growing concern in Sub-Saharan Africa about the spread of the Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, and the public health burden that it ensues.
Emmanuel Ugwu +2 more
core +3 more sources
Suspected Ebolavirus Reservoir Species in Anthropogenic Landscapes
The Bulletin of the Ecological Society of America, Volume 106, Issue 2, April 2025.
Matthew LeBreton, Robert L. Cohen
wiley +1 more source
Vaccine process technology—A decade of progress
Biotechnology and Bioengineering, Volume 121, Issue 9, Page 2604-2635, September 2024.Abstract In the past decade, new approaches to the discovery and development of vaccines have transformed the field. Advances during the COVID‐19 pandemic allowed the production of billions of vaccine doses per year using novel platforms such as messenger RNA and viral vectors.
Barry Buckland +8 more
wiley +1 more source
Immunotherapeutics for Ebola Virus Disease: Hope on the Horizon
Biologics: Targets & Therapy, 2021 Kyle L O’Donnell, Andrea Marzi Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, USACorrespondence: Andrea Marzi Email marzia@niaid.nih ...
O'Donnell KL, Marzi A
doaj